| 4.09 Data as of May 24 |  -0.04 / -0.97%Today’s Change | 2.25 Today|||52-Week Range 4.40 | +70.42% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Baker Bros Advisors Llc |  Buy | 10/29/2012 | 4,282,419 | $3.00 | $12.8M | +49.27% |
Baker Bros Advisors Llc | Buy | 10/29/2012 | 336,639 | $3.00 | $1.0M | +49.27% |
Baker Bros Advisors Llc | Buy | 10/29/2012 | 103,608 | $3.00 | $310.8K | +49.27% |
Varian John W Chief Executive Officer |  Sale | 11/14/2012 | 38,773 | $2.56 | $99.3K | +53.18% |
Kurland Fred Chief Financial Officer & VP-Finance | Sale | 11/14/2012 | 9,111 | $2.56 | $23.3K | +53.18% |
Rubin Paul D CMO & Senior Vice President-Clinical Development | Sale | 3/19/2013 | 6,990 | $3.29 | $23.0K | +21.36% |
Scannon Patrick J Executive Vice President | Sale | 11/14/2012 | 8,773 | $2.56 | $22.5K | +53.18% |
Scannon Patrick J EVP, Chief Scientific Officer & Director | Buy | 5/14/2013 | 10,000 | $1.69 | $16.9K | -2.15% |
Varian John W Chief Executive Officer | Buy | 5/15/2013 | 10,000 | $1.24 | $12.4K | -3.08% |
Rubin Paul D CMO & Senior Vice President-Clinical Development | Buy | 3/28/2013 | 1,498 | $3.32 | $5.0K | +17.19% |
.
